Trials / Completed
CompletedNCT03591367
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We try to assess the potential role of telomerase reverse transcriptase and MicroRNA (miR-155) in diagnosis of non-muscle-invasive bladder cancer and their correlation with stage and grade of the tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MicroRNAs-155 | Quantitative analysis of cell-free miR-155 using RT-qPCR. |
| DIAGNOSTIC_TEST | Human telomerase reverse transcriptase | Analysis TERT by TERT messenger RNA (mRNA)expression by reverse transcription-quantitative polymerase chain reaction. |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2018-07-19
- Last updated
- 2019-11-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03591367. Inclusion in this directory is not an endorsement.